Lifeboat Foundation

A single infusion gene therapy treatment improved levels of the essential blood clotting protein Factor VIII, with 85 percent of patients achieving normal or near-normal levels of the blood clotting factor, even many months after treatment.

Summary: British doctors say they have achieved “mind-blowing” results using gene therapy to rid people of hemophilia A. [This article first appeared on LongevityFacts. Author: Brady Hartman.]

We are one step closer to a cure for hemophilia according to the results of a groundbreaking gene therapy trial published in the New England Journal of Medicine.

Continue reading “Groundbreaking Gene Therapy Trial Aims to Cure Hemophilia” »

New view on mitochondrial DNA could put the brakes on mutations that drive diseases. Scientists perform landmark sequencing of mitochondrial DNA and discover surprising facts.

Summary: New view on mitochondrial DNA could help put the brakes on mutations that drive diseases. [Author: Brady Hartman. This article first appeared on LongevityFacts.]

DNA sequences between mitochondria inside a single cell are vastly different, reported scientists in the Perelman School of Medicine at the University of Pennsylvania. This discovery will help to illuminate the underlying mechanisms of diseases that start with mutations in mitochondrial DNA and provide clues about how patients might respond to specific treatments. The researchers published their findings in the journal Cell Reports this week.

Continue reading “Researchers Discover Key to Diseases in Mitochondrial DNA Mutations” »

See researchers’ recipe for synthetic mesenchymal stem cells, which showed cardiac regenerative potential in mice.

Gene therapy is the process of replacing defective genes with healthy ones, adding new genes to help the body fight or treat disease, or deactivating problem genes. It holds the promise to transform medicine and create options for patients who are living with difficult, and even incurable, diseases. Learn how this innovative therapy works.

Continuous automatic sampling during production aims to keep Danish biotechnology at the forefront. The equipment, and the company behind it, are the result of fruitful collaboration between businesses and universities.

Biotech companies can now take samples from their production as often as they wish, untouched by human hands.

This is all thanks to new equipment developed by start-up company Biomatics Technology. Both the company and product were nurtured in the Biopro network, which involves a number of Danish biotech companies and DTU and the University of Copenhagen.

Read more

Underground settings are becoming increasingly relevant to global security and safety. Rising populations and urbanization are requiring military and civilian first responders to perform their duties below ground in human-made tunnels, underground urban spaces, and natural cave networks. Recognizing that innovative, enhanced technologies could accelerate development of critical lifesaving capabilities, DARPA today announced its newest Grand Challenge: the DARPA Subterranean Challenge, or SubT for short.

https://www.spreaker.com/user/talk4media/beyond-confidence-12-18-2017

Whether or not immortality is possible, whether or not one would like it for oneself, it’s important to keep in mind that it is not what biomedical research against ageing is about.

When doing science, it is crucially important to have clear, unambiguous definitions. These definitions must be firmly established to avoid confusion and misunderstandings and possibly to prevent people from going around telling everyone that you’re working on something that you’re actually not.

The I-word

Continue reading “For the last time: rejuvenation is not immortality” »